neomycin and polymyxin B
sulfates ophthalmic solution, USP
STATROL® (Neomycin and Polymyxin B Sulfates Ophthalmic Ointment, USP) is a sterile ophthalmic drug combining two antibacterials in ointment form. Each gram of ointment contains: Active: Neomycin Sulfate equivalent to 3.5 mg Neomycin base, Polymyxin B Sulfate equal to 10,000 polymyxin B units.
STRATOL Ophthalmic Ointment is indicated in the topical treatment of infections of the external eye and its adnexa caused by susceptible bacteria. Such infections encompass conjunctivitis, keratitis, and keratoconjunctivitis, blepharitis and blepharoconjunctivitis, acute meibomianitis and dacryocystitis.
Clinical Trials Related to Statrol (Neomycin / Polymyxin B Ophthalmic)
Left Ventricular Septum Pacing in Patients by Transvenous Approach Through the Inter-ventricular Septum [Recruiting]
Cardiac pacing is the only effective treatment for symptomatic bradycardia. The right
ventricular apex (RVA) has become the most frequently used ventricular pacing site. However,
RVA pacing has been shown to cause left ventricular (LV) dyssynchrony wich can lead to LV
dysfunction and development of heart failure. Recent studies in animals have demonstrated
that pacing at the LV septum induces significantly less ventricular dyssynchrony than RVA
pacing and is able to improve LV function to a similar degree as biventricular (BiV) pacing.
In addition it was shown that a LV septum lead can be placed permanently by driving a lead
with extended helix from the RV side through the inter-ventricular septum into the LV
endocardial layer. This was shown to be a feasible and safe procedure and lead stability was
shown during four months of follow-up in otherwise healthy and active canines. LV septum
pacing may therefore be a good treatment alternative in patients with symptomatic
bradycardia, as well as patients with an indication for cardiac resynchronization therapy
(CRT). The purpose of this study is to translate the findings from preclinical studies to
the clinical situation by investigating the feasibility, long-term lead stability and safety
of LV septum pacing by transvenous approach through the inter-ventricular septum in
Trial in Cardiac Resynchronization Therapy (CRT) Pacemakers and Dual Chamber (DDD) Pacemakers: Right Ventricular Apex Versus High Posterior Septum [Recruiting]
In heart failure patients we hypothesised that right ventricular high posterior septum is
superior to right ventricular apex in CRT and DDD pacemaker. In two separate trials we
prospectively randomized the right ventricular lead placement to find evidence of
differences in heart failure symptoms (NYHA-class), 6 minute hall walk and echocardiographic
measurements of reverse remodelling and dyssynchrony.
Clearance of Nasal Staphylococcus Aureus With Triple Antibiotic Ointment [Recruiting]
Staphylococcus aureus, a bacteria that lives commonly in the anterior nostrils, is seen in
about 30% of healthcare workers. Applying mupirocin ointment, a prescription, to the
nostrils twice daily for 5 days is the current standard of care for treatment to clear this
bacteria. This research study is designed to determine the rate of clearance of this
bacteria in healthcare workers who are carriers when using triple antibiotic ointment
instead of mupirocin ointment.
Tissue Characterization in Teeth Treated With a Regeneration Protocol [Recruiting]
The purpose of the investigators study is to characterize the composition of the hard and
soft tissues present in root canals of teeth previously diagnosed with necrotic pulps and
incomplete root formation and treated with a triple antibiotic regeneration protocol. The
investigators hypothesis is that treatment of teeth with necrotic pulps and immature apices
with triple antibiotic paste will stimulate continued root formation by the deposition of
dentin at the root apices. The primary outcome measure will be histological identification
of mineralized tissue and adherent cells in the apical third of these teeth.
Bone Substitute in the Multi Traumatized Nasal Septum Reconstruction [Recruiting]
The aim of this project is to evaluate the safety and efficacy of the biomaterial made of
HAP/TCP (BCP, Kasios®), in septoplasties of multi traumatized human nose. The use of this
biomaterial will avoid the graft sampling and we expect it to be a good substitute to
support the nasal pyramid while favouring the respiratory epithelium regeneration. Thus,
that would confirm previous in vitro and in vivo studies.
Page last updated: 2006-09-26